🔗 Share this article

Chancellor Rachel Reeves has announced she is preparing "focused steps to deal with household expense pressures" in next month's Budget.

In comments to media outlets, she noted that curbing price rises is a joint duty of both the government and the Bank of England.

The United Kingdom's price growth is forecast to be the most elevated among the Group of Seven industrialized countries this calendar year and next.

Possible Utility Bill Interventions

Reports indicate the administration could intervene to reduce energy bills, for example by reducing the current 5% rate of value-added tax applied on energy.

A further possibility is to cut some of the regulatory levies presently added to bills.

Budgetary Limitations and Expert Predictions

The administration will receive the latest assessment from the official forecaster, the Office for Budget Responsibility, on the start of the week, which will show how much space there is for such measures.

The view from the majority of analysts is that Reeves will have to announce tax rises or expenditure reductions in order to adhere to her self-imposed debt limits.

Previously on Thursday, analysis showed there was a £22 billion gap for the chancellor to address, which is at the more modest range of expectations.

"There's a shared task between the Bank of England and the administration to bear down further on some of the causes of price increases," Reeves told the BBC in Washington, at the yearly gatherings of the IMF and World Bank.

Revenue Pledges and International Concerns

While much of the attention has been on expected tax increases, the chancellor said the most recent information from the fiscal watchdog had not altered her commitment to manifesto promises not to increase rates on income tax, VAT or social security contributions.

She attributed an "uncertain global environment" with increasing international and commercial concerns for the Budget revenue measures, probably to be focused on those "most able to pay."

International Trade Tensions

Addressing worries about the United Kingdom's trade ties with China she said: "The UK's security interests invariably take priority."

Last week's announcement by China to increase export controls on rare earths and other resources that are key for advanced tech manufacturing led American leader Donald Trump to propose an further 100% tariff on goods from China, increasing the prospect of an all-out commercial conflict between the two global powers.

The US Treasury Secretary labeled the Chinese action "commercial pressure" and "a international production control attempt."

Inquired about accepting the US offer to participate in its conflict with China, Reeves said she was "deeply worried" by Chinese actions and encouraged the Chinese government "to avoid restrictions and restrict access."

She said the move was "harmful for the world economy and generates further obstacles."

"It is my opinion there are areas where we need to challenge China, but there are also important chances to export to China's economy, including banking sector and other areas of the economy. We've got to achieve that balance appropriate."

The chancellor also stated she was collaborating with other major economies "regarding our own critical minerals strategy, so that we are more independent."

Health Service Drug Pricing and Funding

Reeves also acknowledged that the cost the National Health Service pays for pharmaceuticals could rise as a consequence of current talks with the Trump administration and its pharmaceutical firms, in exchange for reduced taxes and funding.

A number of the biggest global pharmaceutical manufacturers have said recently that they are either pausing or canceling operations in the UK, with several attributing the modest returns they are receiving.

Last month, the Science Minister said the price the NHS pays for drugs would need to rise to halt firms and drug research funding leaving the UK.

The Chancellor stated to the BBC: "We have seen due to the cost structure, that drug testing, innovative medicines have not been offered in the UK in the manner that they are in other continental states."

"We want to ensure that people receiving treatment from the National Health Service are able to access the top critical treatments in the world. And so we are examining all of that, and... seeking to obtain increased investment into Britain."